Cargando…

Combination of coumarin and doxorubicin induces drug-resistant acute myeloid leukemia cell death

BACKGROUND: Chemotherapy remains to be the method of choice used by clinicians to treat acute myeloid leukemia (AML) patients. However, the most common problem usually faced in the course of treatment is multidrug resistance (MDR). Nowadays, combination therapy involving natural products as adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Abbas, Nouf S., Shaer, Nehad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988287/ https://www.ncbi.nlm.nih.gov/pubmed/33786386 http://dx.doi.org/10.1016/j.heliyon.2021.e06255

Ejemplares similares

p53 Rather Than β-Catenin Mediated the Combined Hypoglycemic Effect of Cinnamomum cassia (L.) and Zingiber officinale Roscoe in the Streptozotocin-Induced Diabetic Model
por: Ayuob, Nasra, et al.
Publicado: (2021)

Mechanisms of drug resistance in acute myeloid leukemia
por: Zhang, Jing, et al.
Publicado: (2019)

Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia
por: Sherif, Hemat Afifi, et al.
Publicado: (2021)

Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia
por: Yao, Han, et al.
Publicado: (2023)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Characteristics of De Novo Acute Myeloid Leukemia Patients in Palestine: Experience of An-Najah National University Hospital
por: Abuhelwa, Ziad, et al.
Publicado: (2017)

Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia
por: Chen, Mo, et al.
Publicado: (2022)

Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
por: Niu, Jialan, et al.
Publicado: (2022)

Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells
por: Bulut, Ipek, et al.
Publicado: (2022)

A novel coumarin derivative DBH2 inhibits proliferation and induces apoptosis of chronic myeloid leukemia cells
por: Xin, Jiajia, et al.
Publicado: (2022)

A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia
por: Williams, Mark S., et al.
Publicado: (2020)

TP-0903 is active in models of drug-resistant acute myeloid leukemia
por: Jeon, Jae Yoon, et al.
Publicado: (2020)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
por: de Almeida, Luciana Yamamoto, et al.
Publicado: (2021)

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
por: Birsen, Rudy, et al.
Publicado: (2021)

Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts
por: Barwe, Sonali P., et al.
Publicado: (2022)

L. Cucurbita pepo Alleviates Chronic Unpredictable Mild Stress via Modulation of Apoptosis, Neurogenesis, and Gliosis in Rat Hippocampus
por: Ayuob, Nasra, et al.
Publicado: (2021)

Combined venetoclax and alvocidib in acute myeloid leukemia
por: Bogenberger, James, et al.
Publicado: (2017)

Drimane-Type Sesquiterpene Coumarins from Ferula gummosa Fruits Enhance Doxorubicin Uptake in Doxorubicin-Resistant Human Breast Cancer Cell Line
por: Iranshahi, Mehrdad, et al.
Publicado: (2014)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
por: Andresen, Vibeke, et al.
Publicado: (2017)

Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
por: Piccolomo, Antonio, et al.
Publicado: (2020)

Recent drug approvals for acute myeloid leukemia
por: Lai, Catherine, et al.
Publicado: (2019)

Modulation of Drug Resistance in Staphylococcus aureus with Coumarin Derivatives
por: de Araújo, Rodrigo Santos Aquino, et al.
Publicado: (2016)

Targeting regulated cell death pathways in acute myeloid leukemia
por: Garciaz, Sylvain, et al.
Publicado: (2023)

Loss of KDM6A confers drug resistance in acute myeloid leukemia
por: Stief, Sophie M., et al.
Publicado: (2019)

Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
por: Gebru, Melat T., et al.
Publicado: (2020)

Suppressing Hedgehog signaling reverses drug resistance of refractory acute myeloid leukemia
por: Huang, Kaikai, et al.
Publicado: (2019)

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
por: Bolandi, Seyed Mohammadreza, et al.
Publicado: (2021)

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia
por: Zhou, Lixin, et al.
Publicado: (2021)

The Potential Role of 3D In Vitro Acute Myeloid Leukemia Culture Models in Understanding Drug Resistance in Leukemia Stem Cells
por: Al-Kaabneh, Basil, et al.
Publicado: (2022)

Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia)
por: Lin, Min, et al.
Publicado: (2018)

Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2020)

Resistance to targeted therapies in acute myeloid leukemia
por: Mecklenbrauck, Rabea, et al.
Publicado: (2022)

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
por: Kurtz, Stephen E., et al.
Publicado: (2022)

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
por: Turk, Seyhan, et al.
Publicado: (2020)

miR-33a Inhibits the Differentiation of Bovine Preadipocytes through the IRS2–Akt Pathway
por: Zhang, Wenzhen, et al.
Publicado: (2023)

Deregulation of Mitochondrial ATPsyn-β in Acute Myeloid Leukemia Cells and with Increased Drug Resistance
por: Xiao, Xiang, et al.
Publicado: (2013)

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)
por: Mohamed, Aminetou Mint, et al.
Publicado: (2015)

Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
por: Zhai, Xingjian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c0e4c57aqkb3qccu8v2f87tb9c